慢性病患者的限制性vs自由输血策略:一个回顾性队列研究
Mylena Benitez-Valderrama1, Priscila Suárez-Puga1, Jimmy Martin-Delgado1
1Instituto de Investigación en Salud Integral, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador.
概括
针对慢性病患者的限制性红细胞输血策略显示,与自由的方法相比,并发症更少,住院时间更短. 这支持在CKD贫血管理中使用较低的血红蛋白值进行输血.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 贫血是慢性病 (CKD) 的常见并发症,通常需要输血红细胞 (RBC).
- 关于在CKD患者中开始输血的最佳血红蛋白 (Hb) 值进行了辩论.
- 这项研究调查了在住院CKD患者中限制性与自由的输血策略的影响.
研究的目的:
- 为了比较限制性 (Hb≤7g/dl) 与自由的 (Hb>7g/dl) 红细胞输血策略的临床结果.
- 评估输血策略与ICU入院,住院时间和CKD患者不良事件的关联.
主要方法:
- 成年CKD患者 (G3b-G5阶段) 接受红细胞输血的回顾性队列研究.
- 对人口统计数据,并发症和临床结果的分析,包括ICU入院,住院和输血相关的不良事件.
主要成果:
- 限制性输血组 (n=341) 的ICU入院率明显较低 (6.5%对14.7%),不良事件较少.
- 长时间住院 (>10天) 在自由输血组中更常见 (32%对10.5%).
结论:
- 限制性红细胞输血策略与慢性病患者的并发症减少和住院时间缩短有关.
- 这些发现表明,限制性方法可能有利于在住院CKD患者中管理贫血.
相关概念视频
Kidney Transplant I: Introduction
343
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
343
Kidney Transplant II: Surgical Procedure
320
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
320
Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Renal Drug Clearance: Comparison Between Renal Excretion Methods
559
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
559
Kidney Transplant III: Nursing Management
318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209


